Cargando…

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment

Sorafenib, a multi-targeted kinase inhibitor, is the current standard systemic treatment for advanced hepatocellular carcinoma. Sorafenib has anti-angiogenic and anti-proliferative properties and is also known to favor anti-tumor T cell responses by reducing the population of immunosuppressive cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vrecko, Sindy, Guenat, David, Mercier-Letondal, Patricia, Faucheu, Hugues, Dosset, Magalie, Royer, Bernard, Galaine, Jeanne, Boidot, Romain, Kim, Stefano, Jary, Marine, Adotévi, Olivier, Borg, Christophe, Godet, Yann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226040/ https://www.ncbi.nlm.nih.gov/pubmed/30459932 http://dx.doi.org/10.18632/oncotarget.26247

Ejemplares similares

Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)
por: Mercier-Letondal, Patricia, et al.
Publicado: (2021)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
por: Galaine, Jeanne, et al.
Publicado: (2015)

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
por: Dosset, Magalie, et al.
Publicado: (2013)

Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice
por: Rangan, Laurie, et al.
Publicado: (2017)

Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine
por: Seyed, Negar, et al.
Publicado: (2014)

Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
por: Loyon, Romain, et al.
Publicado: (2019)

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
por: Kroemer, Marie, et al.
Publicado: (2020)

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
por: Dosset, Magalie, et al.
Publicado: (2018)

Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
por: Caël, Blandine, et al.
Publicado: (2022)

Remission of psoriasis during treatment with sorafenib
por: van Kester, Marloes S., et al.
Publicado: (2018)

The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017)

Pan-cancer analysis of neoepitopes
por: Teku, Gabriel N., et al.
Publicado: (2018)

Intron retention is a source of neoepitopes in cancer
por: Smart, Alicia C., et al.
Publicado: (2018)

The neoepitope landscape of breast cancer: implications for immunotherapy
por: Narang, Pooja, et al.
Publicado: (2019)

Combination therapies utilizing neoepitope-targeted vaccines
por: Lee, Karin L., et al.
Publicado: (2020)

Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
por: de Sousa, Eric, et al.
Publicado: (2021)

Boosting Antitumor Immunity with an Expanded Neoepitope Landscape
por: Nagel, Remco, et al.
Publicado: (2022)

Citrullination of fibrinogen: generation of neoepitopes and enhancement of immunostimulatory properties
por: Robinson, William H, et al.
Publicado: (2012)

Population-level distribution and putative immunogenicity of cancer neoepitopes
por: Wood, Mary A., et al.
Publicado: (2018)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2017)

Clinical implications of neoepitope landscapes for adult and pediatric cancers
por: Feng, Yang-Yang, et al.
Publicado: (2017)

Circular RNAs as a potential source of neoepitopes in cancer
por: Xia, Jiaqi, et al.
Publicado: (2023)

Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib
por: Liu, Daizhong, et al.
Publicado: (2015)

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2018)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017)

Predicting T cell recognition of MHC class I restricted neoepitopes
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2018)

Machine Learning-Enhanced T Cell Neoepitope Discovery for Immunotherapy Design
por: Martins, Joana, et al.
Publicado: (2019)

Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine
por: Wei, Lixia, et al.
Publicado: (2020)

Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
por: Yu, Huahui, et al.
Publicado: (2021)

Neoepitope fragments as biomarkers for different phenotypes of intervertebral disc degeneration
por: Cui, Shangbin, et al.
Publicado: (2022)

Statistical Analysis and Tokenization of Epitopes to Construct Artificial Neoepitope Libraries
por: Lopez-Martinez, Elena, et al.
Publicado: (2023)

SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction()
por: Ye, Yilin, et al.
Publicado: (2023)

Telomerase and CD4 T Cell Immunity in Cancer
por: Dosset, Magalie, et al.
Publicado: (2020)

The Unfolded Protein Response at the Tumor-Immune Interface
por: Zanetti, Maurizio, et al.
Publicado: (2022)

A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations
por: Toor, Jugmohit S., et al.
Publicado: (2018)

Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
por: James, Eddie A., et al.
Publicado: (2018)

Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
por: Meng, Qingda, et al.
Publicado: (2018)

Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice
por: Dai, Shen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqcecdm9g3pq46objjd6umcf44